Traumatic Brain Injury Treatment Market: By Treatment Type, By Route of Administration, By Distribution Channel, and Region Forecast 2020-2031
Traumatic Brain Injury Treatment Market size was valued at US$ 3.6 billion in 2024 and is expected to reach US$ 5.5 billion by 2031, growing at a CAGR of 6.2% from 2025 to 2031. Traumatic brain injury (TBI) or intracranial injury is an injury to brain due to external force to brain. TBI can be classified as mild, moderate, and severe brain injury. TBI may be occur due to falls, vehicle collision, and violence. Symptoms of traumatic brain injury include cognitive, physical, social, and behavioural symptoms and outcome can range from complete recovery to permanent disability and may causes death. TBI can be diagnosed by using computed tomography (CT) and magnetic resonance imaging (MRIs). In May 2016, Stemedica Cell Technologies, Inc. received FDA investigational new drug (IND) approval for mesenchymal stem cells to treat traumatic brain injury.
Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on the traumatic brain injury therapeutics market growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. This market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Study Period
2025-2031Base Year
2024CAGR
6.2%Largest Market
North-AmericaFastest Growing Market
North-America
Increase in the prevalence of brain traumatic injuries due to rise in number of road accidents and falls is expected to drives the global traumatic brain injuries market over the forecast period. Moreover, rise in number of geriatric population, increase in the R & D for innovation of newer products, promising pipeline products for TBIs, and entry of targeted therapies into the market are expected to boost the global traumatic brain injuries market. However, delayed disease diagnosis, lack of social awareness, and lack of government support for R&D activities are anticipated to restrain the growth of traumatic brain injuries market.
North America traumatic brain injuries treatment market is led by U.S., due to increase in the prevalence of TBIs (According to CDC 2010, approximately 2.5 Mn people are admitted in hospital with TBI and about 138 people die in U.S. with TBIs). Surge in R&D expenditure for the development of newer drugs, and presence of skilled professionals for TBI surgeries are expected to propel the market. Europe traumatic brain injuries treatment market is expected to grow due to adoption of newer techniques for early stage disease diagnosis, promising product pipeline, and increase in the prevalence of TBIs are expected to boost the market. Asia pacific traumatic brain injuries treatment market has significant growth attributed to increase in medical tourism in Asia Pacific region due to low cost of treatment, entry of market players into Asia Pacific, and large patient pool are expected to bolster the market over the forecast years.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 3.6 billion |
|
Market Size in 2031 |
US$ 5.5 billion |
|
Market CAGR |
6.2% |
|
By Treatment Type |
|
|
By Route-administration |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
Traumatic Brain Injury Treatment Market size was valued at US$ 3.6 billion in 2024 and is expected to reach US$ 5.5 billion by 2031, growing at a CAGR of 6.2% from 2025 to 2031.
The traumatic brain injury treatment market key players are TEVA Pharmaceutical Industries Ltd. (Israel) Tenax Therapeutics (U.S.) Amarantus BioScience Holdings (U.S.) Neuren Pharmaceuticals Ltd (Australia) Grace Laboratories LLC. (Georgia) Banyan Biomarkers Inc. (U.S) Vasopharm GmbH Cognosci, Inc. (U.S.) Medicortex Finland Oy (Finland)
The traumatic brain injury treatment market drivers are ongoing product development and approval
| 1.Executive Summary |
| 2.Global Traumatic Brain Injury Treatment Market Introduction |
| 2.1.Global Traumatic Brain Injury Treatment Market - Taxonomy |
| 2.2.Global Traumatic Brain Injury Treatment Market - Definitions |
| 2.2.1.Treatment Type |
| 2.2.2.Route-administration |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Traumatic Brain Injury Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Traumatic Brain Injury Treatment Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Traumatic Brain Injury Treatment Market By Treatment Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Drugs |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Analgesics |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Anti-Convulsants |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Anti-Anxiety Drugs |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Anti-Psychotics |
| 5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Anti-Depressants |
| 5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Anti-Coagulants |
| 5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Others |
| 5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Surgery |
| 5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 6.Global Traumatic Brain Injury Treatment Market By Route-administration, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Parenteral |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Traumatic Brain Injury Treatment Market By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Hospital Pharmacies |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Retail Pharmacies |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Online Stores |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Traumatic Brain Injury Treatment Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Traumatic Brain Injury Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Treatment Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Drugs |
| 9.1.2.Analgesics |
| 9.1.3.Anti-Convulsants |
| 9.1.4.Anti-Anxiety Drugs |
| 9.1.5.Anti-Psychotics |
| 9.1.6.Anti-Depressants |
| 9.1.7.Anti-Coagulants |
| 9.1.8.Others |
| 9.1.9.Surgery |
| 9.2. Route-administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oral |
| 9.2.2.Parenteral |
| 9.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital Pharmacies |
| 9.3.2.Retail Pharmacies |
| 9.3.3.Online Stores |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Traumatic Brain Injury Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drugs |
| 10.1.2.Analgesics |
| 10.1.3.Anti-Convulsants |
| 10.1.4.Anti-Anxiety Drugs |
| 10.1.5.Anti-Psychotics |
| 10.1.6.Anti-Depressants |
| 10.1.7.Anti-Coagulants |
| 10.1.8.Others |
| 10.1.9.Surgery |
| 10.2. Route-administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oral |
| 10.2.2.Parenteral |
| 10.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital Pharmacies |
| 10.3.2.Retail Pharmacies |
| 10.3.3.Online Stores |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Traumatic Brain Injury Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drugs |
| 11.1.2.Analgesics |
| 11.1.3.Anti-Convulsants |
| 11.1.4.Anti-Anxiety Drugs |
| 11.1.5.Anti-Psychotics |
| 11.1.6.Anti-Depressants |
| 11.1.7.Anti-Coagulants |
| 11.1.8.Others |
| 11.1.9.Surgery |
| 11.2. Route-administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oral |
| 11.2.2.Parenteral |
| 11.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital Pharmacies |
| 11.3.2.Retail Pharmacies |
| 11.3.3.Online Stores |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Traumatic Brain Injury Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drugs |
| 12.1.2.Analgesics |
| 12.1.3.Anti-Convulsants |
| 12.1.4.Anti-Anxiety Drugs |
| 12.1.5.Anti-Psychotics |
| 12.1.6.Anti-Depressants |
| 12.1.7.Anti-Coagulants |
| 12.1.8.Others |
| 12.1.9.Surgery |
| 12.2. Route-administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oral |
| 12.2.2.Parenteral |
| 12.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital Pharmacies |
| 12.3.2.Retail Pharmacies |
| 12.3.3.Online Stores |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Traumatic Brain Injury Treatment Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Treatment Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drugs |
| 13.1.2.Analgesics |
| 13.1.3.Anti-Convulsants |
| 13.1.4.Anti-Anxiety Drugs |
| 13.1.5.Anti-Psychotics |
| 13.1.6.Anti-Depressants |
| 13.1.7.Anti-Coagulants |
| 13.1.8.Others |
| 13.1.9.Surgery |
| 13.2. Route-administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oral |
| 13.2.2.Parenteral |
| 13.3. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital Pharmacies |
| 13.3.2.Retail Pharmacies |
| 13.3.3.Online Stores |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.TEVA Pharmaceutical Industries Ltd. (Israel) |
| 14.2.2.Tenax Therapeutics (U.S.) |
| 14.2.3.Amarantus BioScience Holdings (U.S.) |
| 14.2.4.Neuren Pharmaceuticals Ltd (Australia) |
| 14.2.5.Grace Laboratories LLC. (Georgia) |
| 14.2.6.Banyan Biomarkers Inc. (U.S) |
| 14.2.7.Vasopharm GmbH |
| 14.2.8.Cognosci, Inc. (U.S.) |
| 14.2.9.Medicortex Finland Oy (Finland) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
